Cargando…

Multiplexed immunofluorescence identifies high stromal CD68(+)PD-L1(+) macrophages as a predictor of improved survival in triple negative breast cancer

Triple negative breast cancer (TNBC) comprises 10–15% of all breast cancers and has a poor prognosis with a high risk of recurrence within 5 years. PD-L1 is an important biomarker for patient selection for immunotherapy but its cellular expression and co-localization within the tumour immune microen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, James, Browne, Lois, Slapetova, Iveta, Shang, Fei, Lee, Kirsty, Lynch, Jodi, Beretov, Julia, Whan, Renee, Graham, Peter H., Millar, Ewan K. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566595/ https://www.ncbi.nlm.nih.gov/pubmed/34732817 http://dx.doi.org/10.1038/s41598-021-01116-6

Ejemplares similares

TILs Immunophenotype in Breast Cancer Predicts Local Failure and Overall Survival: Analysis in a Large Radiotherapy Trial with Long-Term Follow-Up
por: Millar, Ewan, et al.
Publicado: (2020)

Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer
por: Millar, Ewan KA, et al.
Publicado: (2020)

Survival prediction in triple negative breast cancer using multiple instance learning of histopathological images
por: Sandarenu, Piumi, et al.
Publicado: (2022)

Towards multiplexed immunofluorescence of 3D tissues
por: Cho, Wonjin, et al.
Publicado: (2023)

Live Tissue Imaging to Elucidate Mechanical Modulation of Stem Cell Niche Quiescence
por: Yu, Nicole Y.C., et al.
Publicado: (2016)

Best Practices for Technical Reproducibility Assessment of Multiplex Immunofluorescence
por: Laberiano-Fernández, Caddie, et al.
Publicado: (2021)

Challenges and Opportunities in the Statistical Analysis of Multiplex Immunofluorescence Data
por: Wilson, Christopher M., et al.
Publicado: (2021)

Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy
por: Sheng, Wenjie, et al.
Publicado: (2023)

Multiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD‐L1 immunohistochemistry for predicting response to anti‐PD‐1/PD‐L1 immunotherapy
por: Hu, Weixian
Publicado: (2019)

Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer
por: Sanchez, Katherine, et al.
Publicado: (2021)

Comparison of multiplex, ELISA and immunofluorescence for detecting autoantibodies in JIA patients
por: Fawcett, Paul T, et al.
Publicado: (2012)

Validation of multiplex immunofluorescence for use in analysis of tumour infiltrating lymphocytes
por: Galetta, Henry, et al.
Publicado: (2015)

Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
por: Tan, Wei Chang Colin, et al.
Publicado: (2020)

Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence
por: Mori, Hidetoshi, et al.
Publicado: (2021)

Quantifying and correcting slide-to-slide variation in multiplexed immunofluorescence images
por: Harris, Coleman R, et al.
Publicado: (2022)

Improvement of Opal Multiplex Immunofluorescence Workflow for Human Tissue Sections
por: Willemsen, Marcella, et al.
Publicado: (2021)

Choice of Illumination System & Fluorophore for Multiplex Immunofluorescence on FFPE Tissue Sections
por: Prost, Sandrine, et al.
Publicado: (2016)

Editorial: Multiplex Immunohistochemistry/Immunofluorescence Technique: The Potential and Promise for Clinical Application
por: Fincham, Rachel Elizabeth Ann, et al.
Publicado: (2022)

Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-Profiling Melanoma
por: Yaseen, Zarwa, et al.
Publicado: (2022)

Multiplex Protein Imaging through PACIFIC: Photoactive Immunofluorescence with Iterative Cleavage
por: Ji, Fei, et al.
Publicado: (2023)

Machine-based method for multiplex in situ molecular characterization of tissues by immunofluorescence detection
por: Yarilin, Dmitry, et al.
Publicado: (2015)

Pathology Quality Control for Multiplex Immunofluorescence and Image Analysis Assessment in Longitudinal Studies
por: Lazcano, Rossana, et al.
Publicado: (2021)

Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study
por: Taube, Janis M, et al.
Publicado: (2021)

Companion diagnostic requirements for spatial biology using multiplex immunofluorescence and multispectral imaging
por: Locke, Darren, et al.
Publicado: (2023)

Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1(+)CD8(+) and CD8(+) T cells as predictive of response to neoadjuvant chemotherapy in breast cancer
por: Liang, Hongling, et al.
Publicado: (2020)

A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment
por: Viratham Pulsawatdi, Amélie, et al.
Publicado: (2020)

Cargo and cell-specific differences in extracellular vesicle populations identified by multiplexed immunofluorescent analysis
por: Burbidge, Kevin, et al.
Publicado: (2020)

Oligonucleotide conjugated antibodies permit highly multiplexed immunofluorescence for future use in clinical histopathology
por: McMahon, Nathan P., et al.
Publicado: (2020)

Immunofluorescence versus xTAG multiplex PCR for the detection of respiratory picornavirus infections in children
por: Schindera, Christina, et al.
Publicado: (2010)

Multiplex immunofluorescence-guided laser capture microdissection for spatial transcriptomics of metastatic melanoma tissues
por: Martinek, Jan, et al.
Publicado: (2022)

A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-Immunofluorescence
por: Sulaiman, Raed, et al.
Publicado: (2022)

Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method
por: Lin, Jia-Ren, et al.
Publicado: (2015)

New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay
por: Kallinteris, Nikoletta L, et al.
Publicado: (2015)

The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
por: Taube, Janis M, et al.
Publicado: (2020)

Comparison of Multiplexed Immunofluorescence Imaging to Chromogenic Immunohistochemistry of Skin Biomarkers in Response to Monkeypox Virus Infection
por: Sood, Anup, et al.
Publicado: (2020)

Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer
por: Rashid, Rumana, et al.
Publicado: (2019)

Multiplex Immunofluorescence and Multispectral Imaging: Forming the Basis of a Clinical Test Platform for Immuno-Oncology
por: Hoyt, Clifford C.
Publicado: (2021)

Protocol for multimodal analysis of human kidney tissue by imaging mass spectrometry and CODEX multiplexed immunofluorescence
por: Neumann, Elizabeth K., et al.
Publicado: (2021)

Multiplex Immunofluorescence Tyramide Signal Amplification for Immune Cell Profiling of Paraffin-Embedded Tumor Tissues
por: Hernandez, Sharia, et al.
Publicado: (2021)

Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex Immunofluorescence
por: Peng, Haoxin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_60nq8mf4l4v9e3b2frv955itgs